US 6562861
Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
expired A61PA61P31/04A61P31/12
Quick answer
US patent 6562861 (Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors) held by BioCryst Pharmaceuticals, Inc. expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61P, A61P31/04, A61P31/12, A61P31/16, A61P43/00